Acute neuropathy with multiple conduction blocks after TNFα monoclonal antibody therapy

被引：47

作者：

Singer, OC ^{[1
]}

Otto, B ^{[1
]}

Steinmetz, H ^{[1
]}

Ziemann, U ^{[1
]}

机构：

[1] Univ Frankfurt, Dept Neurol, D-60528 Frankfurt, Germany

来源：

NEUROLOGY | 2004年 / 63卷 / 09期

关键词：

D O I：

10.1212/01.WNL.0000142974.81103.95

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：1754 / 1754

页数：1

共 7 条

[1] TNF neutralization in MS - Results of a randomized, placebo-controlled multicenter study [J].

Arnason, BGW ;

Jacobs, G ;

Hanlon, M ;

Clay, BH ;

Noronha, ABC ;

Auty, A ;

Davis, B ;

Nath, A ;

Bouchard, JP ;

Belanger, C ;

Gosselin, F ;

Thibault, M ;

Duquette, P ;

Bourgoin, P ;

DuBois, R ;

Girard, M ;

Ebers, GC ;

Rice, GPA ;

Vandervoort, MK ;

Francis, GS ;

Duncan, L ;

Lapierre, Y ;

Freedman, MS ;

Christie, SN ;

Rabinovitch, HE ;

Patry, D ;

Murphy, WF ;

Peters, S ;

McGuiness, SD ;

Murray, TJ ;

Bhan, V ;

Maxner, CE ;

Van Dorpe, R ;

Oger, JJ ;

Nelson, J ;

Morrison, W ;

Bogle, N ;

Beall, S ;

Vorobeychick, G ;

Hiltbrunner, AV ;

Bock, J ;

Habil ;

Lesslauer, W ;

Li, DKB ;

Paty, DW ;

Zhao, GJ .

NEUROLOGY, 1999, 53 (03) :457-465

[2]

Foroozan R, 2002, ARCH OPHTHALMOL-CHIC, V120, P985

[3] Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial [J].

Hanauer, SB ;

Feagan, BG ;

Lichtenstein, GR ;

Mayer, LF ;

Schreiber, S ;

Colombel, JF ;

Rachmilewitz, D ;

Wolf, DC ;

Olson, A ;

Bao, WH ;

Rutgeerts, P .

LANCET, 2002, 359 (9317) :1541-1549

[4] Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate:: a randomised phase III trial [J].

Maini, R ;

St Clair, EW ;

Breedveld, F ;

Furst, D ;

Kalden, J ;

Weisman, M ;

Smolen, J ;

Emery, P ;

Harriman, G ;

Feldmann, M ;

Lipsky, P .

LANCET, 1999, 354 (9194) :1932-1939

[5] NEUROLOGICAL DISTURBANCES IN CROHNS-DISEASE [J].

NEUNDORFER, B .

FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 1992, 60 (12) :481-486

[6] Antitumor necrosis factor therapy for inflammatory bowel disease: A review of agents, pharmacology, clinical results, and safety [J].

Sandborn, WJ ;

Hanauer, SB .

INFLAMMATORY BOWEL DISEASES, 1999, 5 (02) :119-133

[7] Drug points - Bilateral anterior toxic optic neuropathy and the use of infliximab [J].

ten Tusscher, MPM ;

Jacobs, PC ;

Busch, MJWM ;

de Graaf, L ;

Diemont, WL .

BRITISH MEDICAL JOURNAL, 2003, 326 (7389) :579-579

← 1 →